Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,663,282
-
Share change
-
-5,526,033
-
Total reported value
-
$1,113,099,854
-
Put/Call ratio
-
120%
-
Price per share
-
$75.91
-
Number of holders
-
65
-
Value change
-
-$435,973,761
-
Number of buys
-
28
-
Number of sells
-
45
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q4 2018
As of 31 Dec 2018,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,663,282 shares.
The largest 10 holders included
Hillhouse Capital Advisors, Ltd., Capital Research Global Investors, HSBC HOLDINGS PLC, York Capital Management Global Advisors, LLC, Temasek Holdings (Private) Ltd, Vanguard Group Inc, BANK OF AMERICA CORP /DE/, FMR LLC, FIL Ltd, and BlackRock Inc..
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.